152 related articles for article (PubMed ID: 34992523)
1. RNA Quality in Post-mortem Human Brain Tissue Is Affected by Alzheimer's Disease.
Highet B; Parker R; Faull RLM; Curtis MA; Ryan B
Front Mol Neurosci; 2021; 14():780352. PubMed ID: 34992523
[TBL] [Abstract][Full Text] [Related]
2. Cell-Specific RNA Quantification in Human SN DA Neurons from Heterogeneous Post-mortem Midbrain Samples by UV-Laser Microdissection and RT-qPCR.
Duda J; Fauler M; Gründemann J; Liss B
Methods Mol Biol; 2018; 1723():335-360. PubMed ID: 29344870
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
Reynolds GP; Mason SL; Meldrum A; De Keczer S; Parnes H; Eglen RM; Wong EH
Br J Pharmacol; 1995 Mar; 114(5):993-8. PubMed ID: 7780656
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
6. TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue.
Barrachina M; Castaño E; Ferrer I
Neurochem Int; 2006 Aug; 49(3):276-84. PubMed ID: 16522342
[TBL] [Abstract][Full Text] [Related]
7. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
[TBL] [Abstract][Full Text] [Related]
8. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders.
Ge J; Barnes NM
Eur J Pharmacol; 1996 Feb; 297(3):299-306. PubMed ID: 8666063
[TBL] [Abstract][Full Text] [Related]
9. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.
Beach TG; Adler CH; Sue LI; Serrano G; Shill HA; Walker DG; Lue L; Roher AE; Dugger BN; Maarouf C; Birdsill AC; Intorcia A; Saxon-Labelle M; Pullen J; Scroggins A; Filon J; Scott S; Hoffman B; Garcia A; Caviness JN; Hentz JG; Driver-Dunckley E; Jacobson SA; Davis KJ; Belden CM; Long KE; Malek-Ahmadi M; Powell JJ; Gale LD; Nicholson LR; Caselli RJ; Woodruff BK; Rapscak SZ; Ahern GL; Shi J; Burke AD; Reiman EM; Sabbagh MN
Neuropathology; 2015 Aug; 35(4):354-89. PubMed ID: 25619230
[TBL] [Abstract][Full Text] [Related]
10. [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].
Schneider G; Oepen H; von Wedel HR
Arch Psychiatr Nervenkr (1970); 1981; 230(1):5-15. PubMed ID: 6455104
[TBL] [Abstract][Full Text] [Related]
11. Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum.
Butterworth NJ; Williams L; Bullock JY; Love DR; Faull RL; Dragunow M
Neuroscience; 1998 Nov; 87(1):49-53. PubMed ID: 9722140
[TBL] [Abstract][Full Text] [Related]
12. RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays.
Koppelkamm A; Vennemann B; Lutz-Bonengel S; Fracasso T; Vennemann M
Int J Legal Med; 2011 Jul; 125(4):573-80. PubMed ID: 21584656
[TBL] [Abstract][Full Text] [Related]
13. Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's, and Parkinson's.
Illes J
Brain Lang; 1989 Nov; 37(4):628-42. PubMed ID: 2479447
[TBL] [Abstract][Full Text] [Related]
14. Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain.
Narayan PJ; Lill C; Faull R; Curtis MA; Dragunow M
Neurobiol Dis; 2015 Feb; 74():281-94. PubMed ID: 25484284
[TBL] [Abstract][Full Text] [Related]
15. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.
Araujo DM; Lapchak PA
Neuroscience; 1994 Aug; 61(4):745-54. PubMed ID: 7838374
[TBL] [Abstract][Full Text] [Related]
16. Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality.
Rochow H; Franz A; Jung M; Weickmann S; Ralla B; Kilic E; Stephan C; Fendler A; Jung K
Theranostics; 2020; 10(20):9268-9279. PubMed ID: 32802191
[No Abstract] [Full Text] [Related]
17. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes.
Dragunow M; Faull RL; Lawlor P; Beilharz EJ; Singleton K; Walker EB; Mee E
Neuroreport; 1995 May; 6(7):1053-7. PubMed ID: 7632894
[TBL] [Abstract][Full Text] [Related]
18. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
[TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
Panegyres PK; Zafiris-Toufexis K; Kakulas BA
J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
[TBL] [Abstract][Full Text] [Related]
20. Letter and semantic fluency in Alzheimer's, Huntington's, and Parkinson's dementias.
Suhr JA; Jones RD
Arch Clin Neuropsychol; 1998 Jul; 13(5):447-54. PubMed ID: 14590609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
